- Home
- MLSS vs AYTU Comparison
MLSS vs AYTU Comparison
Compare MLSS & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLSS | AYTU |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7M | 25.7M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MLSS | AYTU |
|---|---|---|
| Price | $0.28 | $2.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $9.33 |
| AVG Volume (30 Days) | ★ 197.7K | 43.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,973,982.00 | ★ $27,632,080.00 |
| Revenue This Year | $12.64 | N/A |
| Revenue Next Year | $8.99 | $43.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.99 | ★ 277.47 |
| 52 Week Low | $0.22 | $0.98 |
| 52 Week High | $1.11 | $3.07 |
Technical Indicators
Market Signals| Indicator | MLSS | AYTU |
|---|---|---|
| Relative Strength Index (RSI) | 47.38 | 47.22 |
| Support Level | $0.24 | $2.46 |
| Resistance Level | $0.31 | $2.66 |
| Average True Range (ATR) | 0.03 | 0.11 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 21.69 | 20.00 |
Price Performance
Historical ComparisonAbout MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.